Quality Systems – Page 262

Content Uniformity Failure after packaging change: sampling and mixing controls for QA review

Addressing Content Uniformity Failures Following a Packaging Change In the dynamic landscape of pharmaceutical manufacturing, maintaining consistency and quality is paramount. A recent case involving a content uniformity failure after…

Ph Drift in dental paste filling: manufacturing vs lab root cause assessment

Root Cause Assessment for pH Drift in Dental Paste Filling: Manufacturing vs Lab Investigation The challenge of pH drift in dental paste filling can lead to significant complications in both…

Sedimentation Oos during inspection readiness: sanitation, water, and EM checks

Investigating Sedimentation OOS during Inspection Readiness: Key Focus Areas for Quality Assurance In the pharmaceutical manufacturing sector, maintaining compliance during inspection readiness is critical, especially concerning out-of-specification (OOS) findings. One…

Content Uniformity Failure after supplier change: sampling and mixing controls for QA review

Investigating Content Uniformity Failures Post-Supplier Change: Strategies for Quality Assurance In the highly regulated environment of pharmaceutical manufacturing, content uniformity (CU) failures can pose significant challenges, particularly following a change…

E&L Failure in dental paste filling: GMP investigation steps with CAPA

GMP Investigation Steps for E&L Failure in Dental Paste Filling E&L (extractables and leachables) failure during the filling of dental pastes can lead to significant quality concerns and regulatory scrutiny.…

Phase Separation at accelerated stability: investigation steps with CAPA evidence

Steps to Investigate Phase Separation at Accelerated Stability in Otic Dosage Forms Phase separation in otic dosage forms during accelerated stability testing can indicate potential quality failures, leading to Out…

Assay Oos at accelerated stability: GMP investigation steps with CAPA

Addressing Assay OOS in Accelerated Stability: Comprehensive GMP Investigation Steps In the realm of pharmaceutical manufacturing, deviations during quality control testing, specifically Out of Specification (OOS) results, can lead to…

Microbial Limits Failure in dental gel manufacturing: GMP investigation steps with CAPA

GMP Investigation Steps for Microbial Limits Failure in Dental Gel Manufacturing The pharmaceutical industry faces stringent requirements for microbial limits in manufacturing operations, particularly within dental gel formulations. A microbial…

Texture Grittiness Complaint at accelerated stability: packaging compatibility and shelf-life justification

Investigating Texture Grittiness Complaints During Accelerated Stability Testing The integrity of pharmaceutical products is paramount, and complaints regarding texture grittiness during accelerated stability can pose significant challenges in manufacturing and…

Tag: Quality Systems